John Strouse/LinkedIn
Oct 13, 2026, 13:56
John Strouse: Screening for FNAIT – What HDN Teaches Us About Preventing Newborn Intracranial Hemorrhage
John Strouse, Associate Professor of Medicine at Duke University Medical Center, shared a post on LinkedIn:
“Great session on hemolytic disease of the newborn (HDN) as a model for how to screen, prevent and treat fetal and neonatal alloimmune thrombocytopenia (FNAIT), the cause of intracranial hemorrhage in 1 in 10,000 newborns-need more data on risk stratification and prevention in first pregnancy.
Dr. Bussel making the case for screening.”
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 14:40Cheryl Loetscher: This Day in Drug Discovery – Wakix and H3 Receptor Inverse Agonism in Narcolepsy
-
Oct 13, 2026, 14:30Thirunavukkarasu Angappan: FVIII vs. FIX Expressive Durability – Key Lessons from GENEr8-1 and HOPE-B Long-Term Data
-
Oct 13, 2026, 14:25Alyaa Al-Mughairy: Highlights from the 8th Omani Society of Hematology Congress
-
Oct 13, 2026, 14:21Britta Diebel: Reflections on an Unforgettable International Plasma Awareness Week
-
Oct 13, 2026, 14:14ESPHO at MAX Cancer Congress 2026: Advancing Ethiopian Pediatric Oncology on the Global Stage
-
Oct 13, 2026, 14:05Antonella Cordoba: WFH Representatives Visit the Hemophilia Foundation of Argentina
-
Oct 13, 2026, 12:29Mariam Al Mansoori: 5th International Hemophilia Conference
-
Oct 13, 2026, 12:13Hemophilia Outreach of Wisconsin Attends VWD Connect Conference
-
Oct 13, 2026, 11:41Abhishek Kumar: How Three Hemophilia Patients Helped Secure Life-Saving Treatment in Bihar